2019-05-21T08:08:02-05:00 2018-12-31 541149263 YOUNT HYDE & BARBOUR PC PO BOX 2560 WINCHESTER VA 226041760 990 2018-01-01 131772100 NATIONAL PHARMACEUTICAL COUNCIL INC NATI 2028272100 1717 PENNSYLVANIA AVENUE NW NO 800 WASHINGTON DC 20006 KATHRYN GLEASON COO AND SENIOR VP 2028272100 2019-05-20 1 OLIVIA A HUTTON CPA P00964688 5406623417 64.4.100.170 2019-05-20 17:48:19 ED P 2BD9941C2218514039E2696DAFBBB0AADD46666A 2BD9941C2218514039E2696DAFBBB0AADD46666A 2018 2019-02-21 02:37:17Z KATHRYN GLEASON 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 14034011 0 X SEE SCHEDULE O X 1953 NY THE NATIONAL PHARMACEUTICAL COUNCIL (NPC) FOCUSES ON RESEARCH AND DEVELOPMENT, INFORMATION DISSEMINATION, EDUCATION AND COMMUNICATION OF THE CRITICAL ISSUES OF EVIDENCE, INNOVATION AND THE VALUE OF MEDICINES FOR PATIENTS. 22 22 14 0 0 0 0 0 8700000 9250000 791373 91817 0 0 9491373 9341817 0 0 0 0 3027493 4577667 0 0 0 5520834 4770695 8548327 9348362 943046 -6545 17504629 19277031 4280535 6422459 13224094 12854572 TO SPONSOR, PARTICIPATE IN AND PROMOTE THE SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF IMPROVED HEALTH OUTCOMES THROUGH PHARMACEUTICAL INNOVATION. 0 0 THE NATIONAL PHARMACEUTICAL COUNCIL SPONSORS AND CONDUCTS SCIENTIFIC ANALYSES OF THE APPROPRIATE USE OF PHARMACEUTICALS AND THE CLINICAL AND ECONOMIC VALUE OF INNOVATION. THE ORGANIZATION'S STRATEGIC FOCUS IS ON EVIDENCE-BASED MEDICINE (EBM) FOR HEALTH CARE DECISION-MAKING TO ENSURE THAT PATIENTS HAVE ACCESS TO HIGH-QUALITY CARE. ALL ACTIVITIES UNDERTAKEN BY THE COUNCIL RELATE TO THESE FUNCTIONS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 16 0 1 14 1 0 0 0 0 1 1 0 1 0 X 22 22 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X NATIONAL PHARMACEUTICAL COUNCIL 2028272100 1717 PENNSYLVANIA AVE NW NO 800 WASHINGTON DC 20006 DANIEL LEONARD PRESIDENT, CEO 40.00 X X 1304113 0 42945 ROBERT DUBOIS VICE PRESIDENT, CSO 40.00 X X 531083 0 40690 RICHARD BAGGER VICE CHAIR AND TREASURER 1.00 X X 0 0 0 JOSHUA OFMAN IMMEDIATE PAST CHAIR 1.00 X 0 0 0 MARK NAGY CHAIRMAN 1.00 X X 0 0 0 MICHAEL RYAN DIRECTOR 1.00 X 0 0 0 MIKE STAFF DIRECTOR 1.00 X 0 0 0 JAN HANSEN DIRECTOR 1.00 X 0 0 0 DAVID MACARIOS DIRECTOR 1.00 X 0 0 0 SHONTELLE DODSON DIRECTOR 1.00 X 0 0 0 CHRISTINE MARSH DIRECTOR 1.00 X 0 0 0 JENNIFER NORTON DIRECTOR 1.00 X 0 0 0 BLASINE PENKOWSKI DIRECTOR 1.00 X 0 0 0 STEVEN ROMANO DIRECTOR 1.00 X 0 0 0 KYLE HVIDSTEN DIRECTOR 1.00 X 0 0 0 GEORGE KEEFE DIRECTOR 1.00 X 0 0 0 KATHRYN GLEASON COO AND SENIOR VP 40.00 X X 232136 0 20960 MARTIN ZAGARI DIRECTOR 1.00 X 0 0 0 EDWARD FEELEY DIRECTOR 1.00 X 0 0 0 COY A STOUT II DIRECTOR 1.00 X 0 0 0 FRANCOIS LAFLEUR DIRECTOR 1.00 X 0 0 0 LEIGH ANNE LEAS DIRECTOR 1.00 X 0 0 0 JUSTIN MCCARTHY DIRECTOR 1.00 X 0 0 0 JOSEPH W LA BARGE DIRECTOR 1.00 X 0 0 0 PATRICK MAGRI DIRECTOR 1.00 X 0 0 0 JENNIFER GRAFF VP, CER 40.00 X 247066 0 31766 ANDREA HOFELICH VP, COMMUNICATIONS 40.00 X 212826 0 36143 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEAR 40.00 X 245908 0 34873 MICHAEL CIARAMENTARO VP, RESEARCH 40.00 X 245282 0 30687 3018414 0 238064 7 0 1 0 PROJECT HOPE 7500 OLD GEORGETOWN ROAD SUITE 600 BETHESDA MD 20814 RESEARCH 538000 TWIST MARKETING 100 CAMPUS DRIVE SUITE 300 FLORHAM PARK NJ 07932 MARKETING 414682 RTI HEALTH SOLUTIONS PO BOX 14668 RESEARCH TRIANGLE PARK NC 27709 RESEARCH 318662 ANALYSIS GROUP INC 800 WASHINGTON ST BOX 453 BOSTON MA 02111 RESEARCH 280200 DISCERN HEALTH 1120 NORTH CHARLES STREET SUITE 20 BALTIMORE MD 21201 RESEARCH 211789 10 MEMBERSHIP DUES 900099 9250000 9250000 9250000 302810 302810 4481201 4692194 -210993 -210993 -210993 9341817 9250000 0 91817 2980509 713369 49523 683139 151127 117628 67750 53341 843054 71677 215660 331080 75055 146372 69779 28008 PROGRAMS, SPECIAL STUDI 2680022 SUBSCRIPTIONS & MEMBERS 66251 ENTERTAINMENT 5018 9348362 2695403 5361231 601398 389796 275975 322927 660212 463847 258686 196365 13651167 12984712 22000 22000 17504629 19277031 827123 510308 950000 3375000 2503412 2537151 4280535 6422459 X 13224094 12854572 13224094 12854572 17504629 19277031 -6545 -362977 0 X X 0 1 X 1 0 1 1 0 376040 244426 131614 182150 164093 18057 102022 55328 46694 196365 PENSION COST LIABILITY 670738 NONQUALIFIED, DEFERRED COMPENSATION LIABILITY 1720578 DEFERRED LEASE INCENTIVE, NET 145835 2537151 8925499 -362977 -362977 9288476 53341 53341 9341817 9295021 0 9295021 53341 53341 9348362 X 1 1 X X X 0 1 0 DANIEL LEONARD PRESIDENT, CEO 694662 0 344781 0 264670 0 13500 0 29445 0 1347058 0 0 0 ROBERT DUBOIS VICE PRESIDENT, CSO 440933 0 53500 0 36650 0 13500 0 27190 0 571773 0 0 0 KATHRYN GLEASON COO AND SENIOR VP 206722 0 25041 0 373 0 9283 0 11677 0 253096 0 0 0 JENNIFER GRAFF VP, CER 219164 0 27260 0 642 0 11027 0 20739 0 278832 0 0 0 ANDREA HOFELICH VP, COMMUNICATIONS 189371 0 22724 0 731 0 9193 0 26950 0 248969 0 0 0 KIMBERLY WESTRICH VP, HEALTH SERVICES RESEAR 218274 0 27261 0 373 0 11207 0 23666 0 280781 0 0 0 MICHAEL CIARAMENTARO VP, RESEARCH 218000 0 27120 0 162 0 7500 0 23187 0 275969 0 0 0 PART I, LINE 1A DANIEL LEONARD RECEIVES GROSS-UP PAYMENTS TO THE NONQUAILIFIED RETIREMENT PLAN AVAILABLE TO OFFICERS. THESE PAYMENTS ARE INCLUDED IN THEIR TAXABLE COMPENSATION WHEN PAID. PART I, LINE 4B SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN - DANIEL LEONARD - $263,493 FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS REVIEWED BY THE TREASURER AND THE VICE PRESIDENT OF MEMBERSHIP AND OPERATIONS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY COVERS ALL MEMBERS OF THE BOARD, THE OFFICERS, AND STAFF AND IS MONITORED BY ANNUAL WRITTEN INFORMATION QUESTIONNAIRES FROM THE PRESIDENT WHICH ARE REVIEWED AND MAINTAINED BY THE VICE PRESIDENT OF BUSINESS OPERATIONS AND EXTERNAL AFFAIRS. THE BOARD OFFICERS REVIEW EACH TRANSACTION TO COME BEFORE THE BOARD FOR POTENTIAL OR ACTUAL CONFLICTS OF INTEREST. IF ANY POTENTIAL OR ACTUAL CONFLICTS ARE IDENTIFIED THE PERSON DETERMINED TO HAVE A CONFLICT IS RECUSED FROM DELIBERATIONS, VOTING OR ANY ACTIONS RELATED TO THE MATTER. THE IDENTIFIED CONFLICTS WOULD BE DOCUMENTED IN THE MINUTES OF EACH BOARD OR COMMITTEE MEETING. FORM 990, PART VI, SECTION B, LINE 15 THE PROCESS FOR DETERMINING COMPENSATION INCLUDES A REVIEW AND APPROVAL BY THE CHAIRMAN OF BOARD, WHO IS AN INDEPENDENT BOARD MEMBER ELECTED ANNUALLY ON A ROTATING BASIS. COMPARABILITY DATA USED IN THE REVIEW PROCESS IS OBTAINED FROM PUBLIC SOURCES, RECRUITERS, AND OTHER HUMAN RESOURCE PROFESSIONALS. THE AUDIT AND BUDGET COMMITTEE APPROVES TOTAL SALARIES AS APPROVED BY THE CHAIRMAN. THE COMPENSATION DETERMINATION PROCESS APPLIES TO THE MOST RECENT YEAR FOR WHICH THE PROCESS WAS UNDERTAKEN. THE CHAIRMAN OF THE BOARD REVIEWS AND APPROVES THE SALARY FOR THE PRESIDENT. THE PRESIDENT REVIEWS AND APPROVES ALL OTHERS WITHIN THE BUDGET, WHICH ARE ALSO APPROVED BY THE AUDIT AND BUDGET COMMITTEES. ALL SALARIES WERE REVIEWED AND APPROVED IN 2018. FORM 990, PART VI, SECTION C, LINE 19 THE NATIONAL PHARMACEUTICAL COUNCIL DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. FORM 990, PART XII, LINE 2C: PROCESS HAS NOT CHANGED. REASONABLE CAUSE WAIVER REQUEST - IRC 6651, FAILURE TO FILE PENALTY: LATE FILED RETURN DUE TO CCH SOFTWARE OUTAGE. LATE FILED RETURN DUE TO CCH SOFTWARE OUTAGE